Health·Süddeutsche Zeitung·1h agoEuropean Union
EU Approves New Pancreatic Cancer Drug
Daraxonrasib gets accelerated review, like Covid vaccines
Positive1 min readImportance
AI Summary
The European Medicines Agency has granted approval to daraxonrasib, a new drug for pancreatic cancer, using an accelerated review procedure similar to that used for Covid-19 vaccines.
Keywords
pancreatic cancerdaraxonrasibEuropean Medicines Agencydrug approvalaccelerated review
